Inhibition of endothelial cell activation by adenovirus-mediated expression of IκBα, an inhibitor of the transcription factor NF-κB

Journal of Experimental Medicine

Volumn 183, Issue 3, 1996, Pages 1013-1022

  Wrighton, C J ^a,c   Hofer Warbinek, R ^b   Moll, T ^b,d   Eytner, R ^b   Bach, F H ^a,b   De Martin, R ^b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b Vienna International Research Cooperation Center   (Austria)

^c KEELE UNIVERSITY   (United Kingdom)

^d UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR INHIBITOR; TRANSCRIPTION FACTOR INHIBITOR IKAPPA BALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; ELECTROPHORETIC MOBILITY; ENDOTHELIUM CELL; GENE EXPRESSION REGULATION; IMMUNOMODULATION; INHIBITION KINETICS; NONHUMAN; PRIORITY JOURNAL; SWINE; TRANSCRIPTION REGULATION; VIRUS RECOMBINATION;

ADENOVIRIDAE; ANIMALS; AORTA; BASE SEQUENCE; CELL ADHESION; CELL LINE; CELLS, CULTURED; CONSENSUS SEQUENCE; DNA-BINDING PROTEINS; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION, VIRAL; HL-60 CELLS; HUMANS; I-KAPPA B PROTEINS; INTERLEUKIN-1; LIPOPOLYSACCHARIDES; MOLECULAR SEQUENCE DATA; NF-KAPPA B; PROMOTER REGIONS (GENETICS); RECOMBINANT PROTEINS; RECOMBINATION, GENETIC; SWINE; THROMBIN; TUMOR NECROSIS FACTOR-ALPHA; UMBILICAL VEINS;

EID: 0029866569     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.183.3.1013     Document Type: Article

References (62)

1. Baeuerle, P.A., and T. Henkel 1994. Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12: 141-179.
2. Blank, V., P. Kourilsky, and A. Israel. 1992. NF-κB and related proteins: Rel/dorsal homologies meet ankyrin-like repeats. TIBS (Trends Biochem. Sci.). 17:136-140.
3. Liou, H.-C., and D. Baltimore. 1993. Regulation of the NF-κB/rel transcription factor and IκB inhibitor system. Curr. Opin. Cell Biol. 5:477-487.
4. Siebenlist, U., G. Franzoso, and K. Brown. 1994. Structure, regulation and function of NF-κB. Annu. Rev. Cell Biol. 10: 405-455.
5. Ballard, D.W., W.H. Walker, S. Doerre, P. Sista, J.A. Molitor, E.P. Dixon, N.J. Peffer, M. Hennink, and W.C. Greene. 1990. The v-rel oncogene encodes a κB enhancer binding protein that inhibits NF-κB function. Cell. 63:803-814.
6. Ballard, D.W., E.P. Dixon, N.J. Peffer, H. Bogerd, S. Doerre, B. Stein, and W.C. Greene. 1992. The 65-kDa subunit of human NF-κB functions as a potent transcriptional activator and target for v-Rel-mediated repression. Proc. Natl. Acad. Sci. USA. 89:1875-1879.
7. Nolan, G.P., S. Ghosh, H.-C. Liou, P. Tempst, and D. Baltimore. 1991. DNA binding and IkB inhibition of the cloned p65 subuint of NF-κB, a rel-related polypeptide. Cell. 64: 961-969.
8. Ruben, S.M., P.J. Dillon, R. Schreck, T. Henkel, C.-H. Chen, M. Maher, P.A. Baeuerle, and C.A. Rosen. 1991. Isolation of a rel-related human cDNA that potentially encodes the 65-kD subunit of NF-κB. Science (Wash. DC). 251:1490-1493.
9. Ruben, S.M., J.F. Klement, T.A. Coleman, M. Maher, C-H. Chen, and C.A. Rosen. 1992. I-Rel: A novel rel-related protein that inhibits NF-κB transcriptional activity. Genes & Dev. 6:745-760.
10. Ryseck, R.-P., P. Bull, M. Takamiya, V. Bours, U. Siebenlist, P. Dobrzanski, and R. Bravo. 1992. RelB, a new Rel family transcription activator that can interact with p50-NF-κB. Mol. Cell. Biol. 12:674-684.
11. Bours, V., J. Villalobos, P.R. Burd, K. Kelly, and U. Sieben-list. 1990. Cloning of a mitogen-inducible gene encoding a κB DNA-binding protein with homology to the rel oncogene and to cell-cycle motifs. Nature (Lond.). 348:76-80.
12. Ghosh, S., A.M. Gifford, L.R. Riviere, P. Tempst, G P. Nolan, and D. Baltimore. 1990. Cloning of the p50 DNA binding subunit of NF-κB: homology to rel and dorsal. Cell 62: 1019-1029.
13. Kieran, M., V. Blank, F. Logeat, J. Vandekerckhove, F. Lottspeich, O. Le Bail, M.B. Urban, P. Kourilsky, P.A. Baeuerle, and A. Israel. 1990. The DNA binding subunit of NF-κB is identical to factor KBF1 and homologous to the rel oncogene product. Cell. 62:1007-1018.
14. Bours, V., P.R. Burd K. Brown, J. Villalobos, S. Park, R.-P. Ryseck, R. Bravo, K. Kelly, and U. Siebenlist. 1992. A novel mitogen-inducible gene product related to p50/p105-NF-κB participates in transactivation through a κB site. Mol. Cell. Biol. 12:685-695.
15. Mercurio, F., J. Didonato, C. Rosette, and M. Karin 1992. Molecular cloning and characterization of a novel Rel/NF-κB family member displaying structural and functonal homology to NF-κB p50/p105. DNA (NY). 7:523-527.
16. Neri, A., C.-C. Chang, L. Lombardi, M. Salina, P. Corradini, A. T. Maiolo, R.S.K. Chaganti, and R. Dalla-Favera. 1991. B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-κB p50. Cell. 67:1075-1087.
17. Schmid, R.M., N.D. Perkins, C.S. Duckett, P.C. Andrews, and G.J. Nabel. 1991. Cloning of an NF-κB subunit which stimulates HIV transcription in synergy with p65. Nature (Lond.). 352:733-736.
18. Parry, G.C.N., and N. Mackman. 1994. A set of inducible genes expressed by activated human monocytic and endothelial cells contain κB-like sites that specifically bind c-Rel-p65 heterodimers. J. Biol. Chem. 269:20823-20825.
19. Davies, N., S. Ghosh, D.L. Simmons, P. Tempst, H.-C. Liou, D. Baltimore, and H.R. Bose, Jr. 1991. Rel-associated pp40: an inhibitor of the Rel family of transcription factors. Science (Wash. DC). 253:1268-1271.
20. Haskill, S., A.A. Beg, S.M. Tompkins, J.S. Morris, A.D. Yurochko, A. Sampson-Johanne, K. Mondal, P. Ralph, and A.S. Baldwin. 1991. Characterization of an immediate early gene induced in adherent monocytes that encodes IκB-like activity. Cell. 65:1281-1289.
21. Tewari, M., P. Dobrzanski, K. Mohn, D.E. Cressman, J.-C. Hsu, R. Bravo, and R. Taub. 1991. Rapid induction in regenerating liver of RL/IF-1 (an IκB that inhibits NF-κB, RelB-p50 and c-Rel-p50) and PHF, a novel κB site-binding complex. Mol. Cell. Biol 12:2898-2908.
22. de Martin, R., B. Vanhove, Q. Cheng, E. Hofer, V. Csizmadia, H. Winkler, and F.H. Bach. 1993. Cytokine-inducible expression in endothelial cells of an IκBα-like gene is regulated by NFκB. EMBO (Eur. Mol. Biol. Organ.) J. 12:2773-2779.
23. Beg, A.A., S.M. Ruben, R.I. Scheinmann, S. Haskill, C. Rosen, and A.S. Baldwin, Jr. 1992. IκB interacts with the nuclear localization sequences of the subunits of NF-κB: a mechanism for cytoplasmic retention. Genes. & Dev. 6:1899-1913.
24. Zabel, U., T. Henkel, M. dos Santos Silva, and P.A. Baeuerle. 1993. Nuclear uptake control of NF-κB by MAD-3, an IκB protein present in the nucleus. EMBO (Eur. Mol. Biol. Organ.) J. 12:201-211.
25. Brown, K., S Gerstberger, L. Carlson, G. Franzoso, and U. Siebenlist. 1995. Control of IκB-α proteolysis by site-specific, signal-induced phosphorylation. Science (Wash. DC). 267:1485-1488.
26. Brockman, J.A., D.C. Scherer, T.A. Mckinsey, S.M. Hall, X.X. Qi, W. Y. Lee, and D.W. Ballard. 1995. Coupling of a signal response domain in I kappa B alpha to multiple pathways for NF-kappa B activation. Mol. Cell. Biol. 15:2809-2818.
27. Palombella, V.J., O.J. Rando, A.L. Goldberg, and T. Maniatis. 1994. The ubiquitin-proteasome pathway is required for processing the NF-κB1 precurser protein and the activation of NF-κB. Cell. 78:773-785.
28. Traenckner, E.B.-M., S. Wilk, and P.A. Baeuerle. 1994. A proteasome inhibitor prevents activation of NF-κB and stabilizes a newly phosphorylated form of IκB-α that is still bound to NF-κB. EMBO (Eur. Mol. Biol Organ.) J. 13:5433-5441.
29. Sun, S.-C., P.A. Ganchi, D.W. Ballard, and W.C. Greene. 1993 NF-κB controls expression of inhibitor IκBα: evidence for an inducible autoregulatory pathway. Science (Wash. DC). 259:1912-1915.
30. Brown, K., S. Park, T. Kanno, G. Franzoso, and U. Siebenlist. 1993. Mutual regulation of the transcriptional activator NF-κB and its inhibitor, IκB-α. Proc. Natl. Acad. Sci. USA. 90:2532-2536.
31. Scott, M.L., T. Fujita, H.-C. Liou, G.P. Nolan, and D. Baltimore. 1993. The p65 subunit of NF-κB regulates IκB by two distinct mechanisms. Genes & Dev. 7:1266-1276.
32. Cheng, Q., C.A. Cant, T. Moll, R. Hofer-Warbinek, E. Wagner, M.L. Birnstiel, F.H. Bach, and R. de Martin. 1994. NF-κB subunit-specific regulation of the IκBα promoter. J. Biol Chem. 269:13551-13557.
33. Chiao, P.J., S. Miyamoto, and I. Verma. 1994. Autoregulation of IκBα activity. Proc. Natl. Acad. Sci. USA. 91:28-32.
34. Zabel, U., and P.A. Baeuerle. 1990. Purified human IκB can rapidly dissociate the complex of the NF-κB transcription factor with its cognate DNA. Cell. 61:255-265.
35. Warren, J.B. 1990. Large vessel endothelial isolation. In The Endothelium. J.B. Warren, editor. Wiley-Liss, Inc., New York. 263-272.
36. Gomex-Foix, A.M., W.S. Coats, S. Baques, T. Alam, R.D. Gerard, and C.B. Newgard. 1992. Adenovirus-mediated transfer of the muscle glycogen phosphorylase gene into hepatocytes confers altered regulation of glycogen metabolism. J. Biol. Chem. 267:25129-25134.
37. McGrory, W.J., D.S. Bautista, and F.L. Graham. 1988. A simple technique for the rescue of early region I mutations into infectious human adenovirus type 5. Virology. 163:614-617.
38. Graham, F.L., and A.J. Van der Eb. 1973. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology. 52:456-467.
39. Jones, N., and T. Shenk. 1979. An adenovirus type 5 early gene function regulates expression of other early viral genes. Proc. Natl. Acad. Sci. USA. 76:3665-3669.
40. Zipfel, P.F., S.G. Irving, K. Kelly, and U. Siebenlist. 1989. Complexity of the primary genetic respons to mitogenic activation of human T cells. Mol. Cell. Biol. 9:1041-1048.
41. Dignam, J.D., R.M. Lebovitz, and R.G. Roeder. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1475-1489.
42. Moll, T., M. Czyz, H. Holzmüller, R. Hofer-Warbinek, E. Wagner, H. Winkler, F.H. Bach, and E. Hofer. 1995. Regulation of the tissue factor promoter in endothelial cells. J. Biol. Chem. 270:3849-3857.
43. Stuhlmeier, K., V. Csizmadia, Q. Cheng, H. Winkler, and F.H. Bach. 1994. Selective inhibition of E-selectin, ICAM-1 and VCAM-1 in endothelial cells. Eur. J. Immunol. 24:2186-2190.
44. Read, M.A., M.Z. Whitley, A.M. Williams, and T. Collins. 1994. NF-κB and IκBα: an inducible autoregulatory system in endothelial activation. J. Exp. Med. 179:503-512.
45. Yei, S., N. Mittereder, S. Wert, J.A. Whitsett, R.W. Wilmott, and B.C. Trapnell. 1994. In vivo evaluation of the safty of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator cDNA to the lung. Human Gene Therapy. 5:731-744.
46. Lawrence, M.B., and T.A. Springer. 1991. Leucocytes roll on a selectin at physiological flow rates: distinction from and pre-requisite for adhesion through integrins. Cell. 65:859-873.
47. Bennet, C.F., T.P. Condon, S. Grimm, H. Chan, and M.-Y. Chiang. 1994. Inhibition of endothelial cell adhesion molecule expression with antisense oligonucleotides. J. Immunol. 152:3530-3540.
48. Arenzana-Seisdedos, F., J. Thompson, M.S. Rodriguez, F. Bachelerie, D. Thomas, and R.T. Hay. 1995. Inducible nuclear expression of newly synthesized IκBα negatively regulates DNA-binding and transcriptional activities of NF-κB. Mol. Cell Biol. 15:2689-2696.
49. 2 and antioxidants have opposite effects on activation of NF-κB and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. EMBO (Eur. Mol. Biol. Organ.) J. 12:2005-2015.
50. Bielinska, A., R.A. Shivdasani, L. Zhang, and G.J. Nabel. 1990. Regulation of gene expression with double-stranded phosphorothionate oligonucleotides. Science (Wash. DC). 250: 997-1000.
51. Lin, Y.Z., S.Y. Yao, R.A. Veach, T.R. Torgerson, and J. Hawiger. 1995. Inhibition of nuclear translocation of transcription factor NF-κB by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence. J. Biol. Chem. 270:14255-14258.
52. Frantz, B., E.C. Nordby, G. Bren, N. Steffan, C.V. Paya, R.L. Kincaid, M.J. Tocci, S.J. O'Keefe, and E.A. O'Neill. 1994. Calcineurin acts in synergy with PMA to inactivate IκB/MAD3, an inhibitor of NF-κB. EMBO (Eur. Mol. Biol. Organ.) J. 13:861-870.
53. Lemarchand, P., H.A. Jaffe, C. Danel, M.C. Cid, H.K. Kleinmann, L.D. Stratford-Perricaudet, M. Perricaudet, A. Pavirani, J.-P. Lecoq, and R. Crystal. 1992. Adenovirus-mediated transfer of a recombinant human a1-antitrypsin cDNA to human endothelial cells. Proc. Natl. Acad. Sci. USA. 89:6482-6486.
54. Morsy, M.A., E.L. Alford, A. Bett, F.L. Graham, and C.T. Caskey. 1993. Efficient adenoviral-mediated ornithine transcarbamylase expression in deficient mouse and human hepatocytes. J. Clin. Invest. 92:1580-1586.
55. Chen, S.J., J.M. Wilson, and D.W. Muller. 1994. Adenovirus-mediated gene transfer of soluble vascular cell adhesion molecule to porcine interposition vein grafts. Circulation. 89: 1922-1928.
56. Ohno, T., D. Gordon, H. San, V.J. Pompili, M.J. Imperiale, G.J. Nabel, and E.G., Nabel. 1994. Gene therapy for vascular smooth muscle cell proliferation after arterial injury. Science (Lond.). 265:781-784.
57. Pober, J.S., and R.S. Cotran. 1990. The role of endothelial cells in inflammation. Transplantation (Baltimore). 50:537-567.
58. McElvaney, N.G., and R.G. Crystal. 1995. IL-6 release and airway administration of human CFTR. cDNA adenovirus vector. Nature Medicine. 1:182-184.
59. Lasky, L.A. 1992. Selectins: interpreters of cell-specific carbohydrate information during inflammation. Science (Wash. DC). 258:964-969.
60. Butcher, E.C. 1991. Leucocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell 67: 1033-1036.
61. Scheinman, R.I., P.C. Cogswell, A.K. Lofquist, and A.S. Baldwin. 1995. Role of transcriptional activation of IκBα in mediation of immunosuppression by glucocorticoids. Science (Wash. DC). 270:283-286.
62. Auphan, N., J.A. DiDonato, C. Rosette, A. Helmberg, and M. Karin. 1995. Immunosuppression by glucocorticoids: inhibition of NF-κB activity through induction of IκB synthesis. Science (Wash. DC). 270:286-290.